npj Parkinson s Disease · 2022 · 33 citations · 45 references
Life SciencesNeurologyNeuroscienceMolecular NeurobiologyMolecular NeuroscienceSignal TransductionMicroglia BiologyNeurodegeneration MechanismsNeurodegenerative DiseasesNeurodegenerative DisordersNeuroinflammationParkinson DiseaseCathepsin ActivityExosomesExtracellular Vesicle ReleaseExtracellular Vesicle-mediated ReleaseGlial-mediated NeurotoxicityMicroglia ActivationMicroglial Responses To InjuryNeurotoxic Action
Uncontrolled microglial activation is pivotal to the pathogenesis of Parkinson's disease (PD), which can secrete Cathepsin L (CTSL) to affect the survival of neurons in the PD patients; however, the precise mechanism has yet to be determined. We demonstrated for the first time that CTSL was mostly released by exosomes derived from α-Syn-activated microglia, resulting in neuronal damage and death. The elevation of CTSL activity was blocked by GW4869, suggesting a critical role for exosomes in mediating CTSL release. Furthermore, the P2X7R/PI3K/AKT signalling pathway was identified as the underlying molecular mechanism since specific antagonists of this signalling pathway, P2X7R knockdown and exosome release inhibitors significantly reduced the injury to cultured mouse cortical neurons. Our study suggests that increased extracellular release of CTSL from α-Syn-activated microglia through exosomes amplifies and aggravates of the neurotoxic effect of microglia, implying that CTSL may be involved in a fresh mechanism of PD pathogenesis, and serve as a potential biomarker and a target for PD drug development.
45
Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response
Gang Chen, Alexander C. Huang, Wei Zhang et al. · Nature · 2018 · 2.8K citations · Full text
Life Sciences, Immunology, Oncology +14
Jacob Bendor, Todd P. Logan, Robert H. Edwards · Neuron · 2013 · 861 citations · Full text
Susan M. Rueter, John Q. Trojanowski, Virginia M.‐Y. Lee · Journal of Neuroscience · 2000 · 749 citations · Full text